Aline Andres
Concepts (325)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Body Composition | 17 | 2024 | 349 | 4.960 |
Why?
| Milk, Human | 16 | 2023 | 109 | 4.800 |
Why?
| Breast Feeding | 23 | 2023 | 189 | 4.000 |
Why?
| Adiposity | 9 | 2024 | 142 | 3.770 |
Why?
| Obesity | 26 | 2024 | 1197 | 3.560 |
Why?
| Body Mass Index | 21 | 2024 | 712 | 3.460 |
Why?
| Weight Gain | 13 | 2023 | 243 | 3.250 |
Why?
| Pregnancy | 40 | 2024 | 2620 | 2.960 |
Why?
| Exercise | 9 | 2024 | 548 | 2.480 |
Why?
| Infant Formula | 18 | 2023 | 152 | 2.420 |
Why?
| Adipose Tissue | 7 | 2024 | 207 | 2.390 |
Why?
| Mothers | 6 | 2024 | 247 | 2.250 |
Why?
| Child Development | 9 | 2021 | 204 | 2.130 |
Why?
| Maternal Nutritional Physiological Phenomena | 6 | 2021 | 51 | 2.130 |
Why?
| Overweight | 9 | 2024 | 239 | 2.010 |
Why?
| Breast Milk Expression | 2 | 2023 | 5 | 1.820 |
Why?
| Milk | 9 | 2023 | 94 | 1.780 |
Why?
| Oligosaccharides | 4 | 2022 | 45 | 1.770 |
Why?
| Pregnancy Complications | 10 | 2023 | 384 | 1.740 |
Why?
| Female | 74 | 2024 | 28418 | 1.730 |
Why?
| Infant | 34 | 2023 | 3817 | 1.730 |
Why?
| Absorptiometry, Photon | 7 | 2023 | 174 | 1.620 |
Why?
| Insulin Resistance | 8 | 2021 | 300 | 1.520 |
Why?
| Plethysmography | 5 | 2020 | 45 | 1.490 |
Why?
| Longitudinal Studies | 15 | 2023 | 746 | 1.370 |
Why?
| Follicular Fluid | 2 | 2019 | 11 | 1.300 |
Why?
| Humans | 82 | 2024 | 54246 | 1.270 |
Why?
| Pregnant Women | 5 | 2022 | 80 | 1.270 |
Why?
| Infant Nutritional Physiological Phenomena | 7 | 2023 | 60 | 1.250 |
Why?
| Infant Food | 3 | 2020 | 31 | 1.230 |
Why?
| Cohort Studies | 14 | 2024 | 1543 | 1.230 |
Why?
| Bottle Feeding | 5 | 2020 | 40 | 1.220 |
Why?
| Diet | 13 | 2024 | 597 | 1.120 |
Why?
| Postpartum Period | 4 | 2023 | 118 | 1.110 |
Why?
| Child, Preschool | 15 | 2024 | 4146 | 1.070 |
Why?
| Magnetic Resonance Spectroscopy | 2 | 2020 | 253 | 1.020 |
Why?
| Metabolome | 3 | 2020 | 109 | 0.970 |
Why?
| Infant, Newborn | 20 | 2023 | 2907 | 0.960 |
Why?
| Lipid Metabolism | 4 | 2019 | 194 | 0.900 |
Why?
| Growth | 3 | 2020 | 43 | 0.890 |
Why?
| Eating | 2 | 2021 | 155 | 0.890 |
Why?
| Prenatal Care | 3 | 2023 | 116 | 0.870 |
Why?
| Blood Glucose | 3 | 2020 | 488 | 0.850 |
Why?
| Child | 16 | 2024 | 7337 | 0.850 |
Why?
| Isoleucine | 1 | 2021 | 25 | 0.840 |
Why?
| Sleep | 1 | 2023 | 186 | 0.840 |
Why?
| Anthropometry | 5 | 2024 | 96 | 0.830 |
Why?
| Adult | 25 | 2023 | 14182 | 0.820 |
Why?
| Pregnancy Trimester, First | 2 | 2023 | 32 | 0.820 |
Why?
| Homeostasis | 2 | 2020 | 223 | 0.800 |
Why?
| Monosaccharides | 1 | 2020 | 6 | 0.780 |
Why?
| Leptin | 3 | 2022 | 154 | 0.770 |
Why?
| Dietary Proteins | 2 | 2020 | 229 | 0.750 |
Why?
| Pregnancy Trimester, Third | 1 | 2020 | 66 | 0.740 |
Why?
| Parents | 2 | 2022 | 344 | 0.740 |
Why?
| Isoflavones | 4 | 2009 | 83 | 0.740 |
Why?
| Maternal-Fetal Exchange | 1 | 2020 | 45 | 0.740 |
Why?
| Early Growth Response Protein 1 | 3 | 2016 | 39 | 0.710 |
Why?
| Body Weight | 3 | 2021 | 578 | 0.690 |
Why?
| Male | 33 | 2024 | 27312 | 0.690 |
Why?
| Fertilization in Vitro | 1 | 2019 | 36 | 0.680 |
Why?
| Lactation | 4 | 2023 | 61 | 0.640 |
Why?
| Soy Milk | 6 | 2018 | 39 | 0.640 |
Why?
| Directive Counseling | 1 | 2017 | 24 | 0.590 |
Why?
| Oocytes | 1 | 2017 | 94 | 0.580 |
Why?
| Ovary | 2 | 2016 | 105 | 0.570 |
Why?
| Antioxidants | 1 | 2019 | 297 | 0.570 |
Why?
| C-Reactive Protein | 1 | 2017 | 159 | 0.560 |
Why?
| Triglycerides | 1 | 2017 | 195 | 0.550 |
Why?
| Prenatal Diagnosis | 1 | 2016 | 108 | 0.550 |
Why?
| Body Water | 2 | 2012 | 34 | 0.530 |
Why?
| Sexual Development | 1 | 2015 | 7 | 0.530 |
Why?
| Genitalia, Male | 1 | 2015 | 13 | 0.530 |
Why?
| Patient Compliance | 1 | 2017 | 249 | 0.530 |
Why?
| Soybean Proteins | 4 | 2020 | 152 | 0.520 |
Why?
| Genitalia, Female | 1 | 2015 | 20 | 0.520 |
Why?
| Soy Foods | 1 | 2015 | 23 | 0.520 |
Why?
| Behavior Therapy | 1 | 2017 | 203 | 0.520 |
Why?
| Child of Impaired Parents | 1 | 2015 | 46 | 0.510 |
Why?
| Gestational Age | 4 | 2019 | 435 | 0.450 |
Why?
| Oxidative Stress | 1 | 2019 | 958 | 0.450 |
Why?
| Infant Behavior | 1 | 2012 | 18 | 0.430 |
Why?
| Bone Density | 2 | 2023 | 416 | 0.430 |
Why?
| Animals | 17 | 2023 | 14385 | 0.420 |
Why?
| Case-Control Studies | 4 | 2019 | 1228 | 0.390 |
Why?
| Military Personnel | 2 | 2023 | 174 | 0.390 |
Why?
| Umbilical Cord | 3 | 2017 | 33 | 0.390 |
Why?
| Feeding Behavior | 2 | 2024 | 199 | 0.370 |
Why?
| Insulin | 4 | 2022 | 510 | 0.370 |
Why?
| Food Supply | 2 | 2023 | 95 | 0.370 |
Why?
| Young Adult | 7 | 2023 | 4308 | 0.360 |
Why?
| Linear Models | 2 | 2021 | 309 | 0.360 |
Why?
| Risk Factors | 5 | 2023 | 3930 | 0.360 |
Why?
| Phenotype | 3 | 2023 | 820 | 0.360 |
Why?
| Viruses | 1 | 2009 | 21 | 0.350 |
Why?
| Magnetic Resonance Imaging | 3 | 2020 | 1604 | 0.340 |
Why?
| Virus Diseases | 1 | 2009 | 44 | 0.340 |
Why?
| Rotavirus | 2 | 2009 | 10 | 0.340 |
Why?
| Antiviral Agents | 1 | 2009 | 188 | 0.320 |
Why?
| Speech Perception | 3 | 2016 | 90 | 0.310 |
Why?
| Breast | 2 | 2023 | 92 | 0.300 |
Why?
| Inflammation | 3 | 2017 | 674 | 0.300 |
Why?
| Placenta | 2 | 2020 | 135 | 0.270 |
Why?
| Diffusion Tensor Imaging | 3 | 2023 | 97 | 0.250 |
Why?
| Heart | 2 | 2020 | 360 | 0.250 |
Why?
| DNA Methylation | 2 | 2020 | 574 | 0.250 |
Why?
| Vagus Nerve | 2 | 2015 | 27 | 0.250 |
Why?
| Fast Foods | 1 | 2023 | 12 | 0.240 |
Why?
| Arkansas | 4 | 2020 | 2094 | 0.240 |
Why?
| Evoked Potentials | 2 | 2016 | 69 | 0.240 |
Why?
| Sodium, Dietary | 1 | 2023 | 27 | 0.230 |
Why?
| Birth Weight | 2 | 2015 | 126 | 0.230 |
Why?
| Prospective Studies | 5 | 2023 | 2604 | 0.230 |
Why?
| Matrix Attachment Region Binding Proteins | 1 | 2023 | 31 | 0.230 |
Why?
| Feces | 2 | 2021 | 135 | 0.230 |
Why?
| Intention | 1 | 2023 | 44 | 0.230 |
Why?
| Amino Acids, Branched-Chain | 2 | 2021 | 44 | 0.220 |
Why?
| Accelerometry | 1 | 2022 | 9 | 0.220 |
Why?
| Bone Diseases, Metabolic | 1 | 2023 | 82 | 0.220 |
Why?
| Hypersensitivity | 1 | 2023 | 82 | 0.220 |
Why?
| Metabolomics | 2 | 2020 | 149 | 0.220 |
Why?
| Diet, High-Fat | 3 | 2020 | 216 | 0.220 |
Why?
| Follow-Up Studies | 3 | 2019 | 2387 | 0.210 |
Why?
| Immunoglobulin A | 1 | 2021 | 54 | 0.210 |
Why?
| Educational Status | 1 | 2023 | 259 | 0.210 |
Why?
| Cross-Sectional Studies | 2 | 2021 | 1679 | 0.210 |
Why?
| Metabolic Networks and Pathways | 2 | 2019 | 104 | 0.200 |
Why?
| Depressive Disorder, Major | 1 | 2023 | 159 | 0.200 |
Why?
| Antibodies, Viral | 1 | 2021 | 124 | 0.200 |
Why?
| Leucine | 1 | 2021 | 113 | 0.200 |
Why?
| Cattle | 3 | 2020 | 224 | 0.190 |
Why?
| Body Fat Distribution | 1 | 2020 | 11 | 0.190 |
Why?
| Urinalysis | 1 | 2020 | 50 | 0.190 |
Why?
| Predictive Value of Tests | 2 | 2016 | 1048 | 0.190 |
Why?
| Body Weights and Measures | 1 | 2020 | 19 | 0.190 |
Why?
| Adolescent | 3 | 2019 | 6885 | 0.180 |
Why?
| Brain | 6 | 2023 | 1387 | 0.180 |
Why?
| Physical Conditioning, Animal | 1 | 2020 | 58 | 0.180 |
Why?
| Models, Biological | 2 | 2020 | 823 | 0.180 |
Why?
| Health Behavior | 1 | 2022 | 273 | 0.180 |
Why?
| Transcriptome | 3 | 2018 | 346 | 0.180 |
Why?
| Health Status | 2 | 2020 | 368 | 0.180 |
Why?
| Exercise Therapy | 1 | 2020 | 123 | 0.170 |
Why?
| Insulin-Like Growth Factor I | 1 | 2019 | 137 | 0.170 |
Why?
| Feasibility Studies | 1 | 2020 | 398 | 0.170 |
Why?
| Uric Acid | 1 | 2019 | 32 | 0.170 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2020 | 377 | 0.170 |
Why?
| Diabetes, Gestational | 1 | 2019 | 54 | 0.170 |
Why?
| GABAergic Neurons | 1 | 2018 | 14 | 0.170 |
Why?
| Sex Factors | 4 | 2018 | 765 | 0.170 |
Why?
| Purines | 1 | 2018 | 45 | 0.160 |
Why?
| Real-Time Polymerase Chain Reaction | 2 | 2016 | 206 | 0.160 |
Why?
| Exosomes | 1 | 2018 | 45 | 0.160 |
Why?
| Maternal Exposure | 1 | 2018 | 87 | 0.160 |
Why?
| Adipogenesis | 2 | 2016 | 52 | 0.160 |
Why?
| Oocyte Retrieval | 1 | 2017 | 6 | 0.150 |
Why?
| Pilot Projects | 1 | 2020 | 808 | 0.150 |
Why?
| Inhibitor of Differentiation Proteins | 1 | 2017 | 7 | 0.150 |
Why?
| Ovulation Induction | 1 | 2017 | 14 | 0.150 |
Why?
| Chemokine CXCL2 | 1 | 2017 | 14 | 0.150 |
Why?
| Dual Specificity Phosphatase 1 | 1 | 2017 | 10 | 0.150 |
Why?
| Fatty Liver | 1 | 2018 | 129 | 0.150 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 673 | 0.150 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2020 | 596 | 0.150 |
Why?
| Parity | 1 | 2017 | 51 | 0.150 |
Why?
| Ideal Body Weight | 1 | 2017 | 7 | 0.150 |
Why?
| Single-Cell Analysis | 1 | 2017 | 56 | 0.150 |
Why?
| Friends | 1 | 2017 | 21 | 0.150 |
Why?
| Organ Size | 2 | 2015 | 237 | 0.150 |
Why?
| Gene Expression Profiling | 3 | 2017 | 1138 | 0.150 |
Why?
| Tumor Necrosis Factor-alpha | 2 | 2016 | 434 | 0.150 |
Why?
| Sequence Analysis, RNA | 1 | 2017 | 107 | 0.140 |
Why?
| Receptors, Interleukin-8A | 1 | 2016 | 6 | 0.140 |
Why?
| Chemokine CXCL11 | 1 | 2016 | 6 | 0.140 |
Why?
| Granulosa Cells | 1 | 2016 | 12 | 0.140 |
Why?
| Versicans | 1 | 2016 | 10 | 0.140 |
Why?
| Glucose Transporter Type 4 | 1 | 2016 | 23 | 0.140 |
Why?
| Chemokine CXCL10 | 1 | 2016 | 20 | 0.140 |
Why?
| Receptors, CCR2 | 1 | 2016 | 14 | 0.140 |
Why?
| Monosaccharide Transport Proteins | 1 | 2016 | 15 | 0.140 |
Why?
| Amino Acids | 1 | 2019 | 369 | 0.140 |
Why?
| Tissue Array Analysis | 1 | 2016 | 50 | 0.140 |
Why?
| Food, Formulated | 2 | 2023 | 44 | 0.140 |
Why?
| Sex Characteristics | 2 | 2018 | 214 | 0.140 |
Why?
| Immunoblotting | 1 | 2016 | 134 | 0.140 |
Why?
| Chemokine CCL2 | 1 | 2016 | 78 | 0.140 |
Why?
| Guidelines as Topic | 1 | 2017 | 125 | 0.140 |
Why?
| Phosphoproteins | 1 | 2016 | 116 | 0.130 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 176 | 0.130 |
Why?
| Nerve Tissue Proteins | 1 | 2017 | 199 | 0.130 |
Why?
| Family | 1 | 2017 | 191 | 0.130 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 153 | 0.130 |
Why?
| Rats, Sprague-Dawley | 2 | 2016 | 1663 | 0.130 |
Why?
| RNA, Messenger | 2 | 2016 | 1202 | 0.130 |
Why?
| Carrier Proteins | 1 | 2017 | 359 | 0.130 |
Why?
| Tissue Plasminogen Activator | 1 | 2016 | 124 | 0.130 |
Why?
| Cerebral Cortex | 1 | 2016 | 234 | 0.130 |
Why?
| Ultrasonography | 2 | 2015 | 480 | 0.130 |
Why?
| Premature Birth | 1 | 2017 | 154 | 0.130 |
Why?
| Neoplasm Proteins | 1 | 2017 | 359 | 0.120 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2020 | 481 | 0.120 |
Why?
| MicroRNAs | 1 | 2018 | 386 | 0.120 |
Why?
| Autonomic Nervous System | 1 | 2015 | 75 | 0.120 |
Why?
| Up-Regulation | 1 | 2016 | 508 | 0.120 |
Why?
| Prognosis | 1 | 2019 | 2118 | 0.120 |
Why?
| Gene Expression Regulation | 2 | 2020 | 1062 | 0.120 |
Why?
| Deuterium Oxide | 1 | 2012 | 9 | 0.110 |
Why?
| Immunohistochemistry | 1 | 2016 | 1089 | 0.110 |
Why?
| Air | 1 | 2012 | 26 | 0.110 |
Why?
| Time Factors | 1 | 2020 | 3212 | 0.110 |
Why?
| Liver | 1 | 2018 | 1225 | 0.110 |
Why?
| Disease Susceptibility | 1 | 2012 | 95 | 0.110 |
Why?
| Life Style | 2 | 2023 | 156 | 0.110 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 541 | 0.110 |
Why?
| Bacteria | 3 | 2022 | 258 | 0.100 |
Why?
| RNA, Ribosomal, 16S | 2 | 2022 | 106 | 0.100 |
Why?
| Swine | 2 | 2010 | 431 | 0.100 |
Why?
| Electroencephalography | 3 | 2023 | 356 | 0.100 |
Why?
| Cell Differentiation | 1 | 2014 | 720 | 0.100 |
Why?
| Evoked Potentials, Auditory | 1 | 2011 | 98 | 0.100 |
Why?
| Sensitivity and Specificity | 1 | 2012 | 923 | 0.090 |
Why?
| Calibration | 1 | 2010 | 59 | 0.090 |
Why?
| Genitalia | 1 | 2009 | 15 | 0.090 |
Why?
| Radionuclide Imaging | 1 | 2010 | 130 | 0.090 |
Why?
| Phytoestrogens | 1 | 2009 | 20 | 0.090 |
Why?
| Anticarcinogenic Agents | 1 | 2009 | 35 | 0.090 |
Why?
| Genistein | 1 | 2009 | 46 | 0.090 |
Why?
| United States | 2 | 2020 | 5200 | 0.090 |
Why?
| Biological Availability | 1 | 2009 | 131 | 0.090 |
Why?
| Flavonoids | 1 | 2009 | 62 | 0.090 |
Why?
| Species Specificity | 1 | 2009 | 205 | 0.090 |
Why?
| Cell Line | 2 | 2013 | 1153 | 0.080 |
Why?
| Reproducibility of Results | 1 | 2012 | 1304 | 0.080 |
Why?
| Palmitates | 2 | 2022 | 28 | 0.080 |
Why?
| Gastrointestinal Diseases | 1 | 2009 | 126 | 0.080 |
Why?
| Gastrointestinal Tract | 1 | 2009 | 135 | 0.080 |
Why?
| Rifabutin | 1 | 2007 | 5 | 0.080 |
Why?
| Lactams, Macrocyclic | 1 | 2007 | 14 | 0.080 |
Why?
| Benzoquinones | 1 | 2007 | 33 | 0.080 |
Why?
| Microscopy, Electron, Transmission | 1 | 2007 | 87 | 0.080 |
Why?
| Etoposide | 1 | 2007 | 85 | 0.080 |
Why?
| Analysis of Variance | 3 | 2014 | 635 | 0.070 |
Why?
| Estradiol | 1 | 2007 | 219 | 0.070 |
Why?
| Regression Analysis | 2 | 2017 | 445 | 0.070 |
Why?
| Language Development | 2 | 2016 | 31 | 0.060 |
Why?
| Mice | 3 | 2020 | 6413 | 0.060 |
Why?
| Mice, Inbred C57BL | 2 | 2020 | 1999 | 0.060 |
Why?
| Disease Models, Animal | 1 | 2009 | 1639 | 0.060 |
Why?
| Food Handling | 1 | 2023 | 37 | 0.060 |
Why?
| Vitamins | 1 | 2023 | 72 | 0.060 |
Why?
| Osteocalcin | 1 | 2023 | 46 | 0.060 |
Why?
| Alkaline Phosphatase | 1 | 2023 | 99 | 0.060 |
Why?
| Syndrome | 1 | 2023 | 252 | 0.060 |
Why?
| Nutritional Status | 1 | 2023 | 158 | 0.050 |
Why?
| Nutrition Surveys | 1 | 2023 | 121 | 0.050 |
Why?
| Energy Intake | 1 | 2023 | 196 | 0.050 |
Why?
| Butyrates | 1 | 2022 | 35 | 0.050 |
Why?
| Immunization, Passive | 1 | 2021 | 35 | 0.050 |
Why?
| Self Report | 1 | 2022 | 204 | 0.050 |
Why?
| Carnitine | 1 | 2022 | 86 | 0.050 |
Why?
| Phonetics | 2 | 2011 | 49 | 0.050 |
Why?
| Weight Loss | 1 | 2023 | 271 | 0.050 |
Why?
| RNA, Viral | 1 | 2021 | 141 | 0.050 |
Why?
| Health Promotion | 1 | 2023 | 300 | 0.050 |
Why?
| Electric Impedance | 1 | 2020 | 43 | 0.050 |
Why?
| Age Factors | 2 | 2014 | 1195 | 0.050 |
Why?
| Optical Imaging | 1 | 2020 | 30 | 0.050 |
Why?
| National Institutes of Health (U.S.) | 1 | 2020 | 49 | 0.050 |
Why?
| CpG Islands | 1 | 2020 | 104 | 0.040 |
Why?
| Bone and Bones | 1 | 2023 | 516 | 0.040 |
Why?
| Transcription Factors | 1 | 2023 | 622 | 0.040 |
Why?
| Energy Metabolism | 1 | 2022 | 311 | 0.040 |
Why?
| Language | 1 | 2020 | 138 | 0.040 |
Why?
| Metagenomics | 1 | 2018 | 38 | 0.040 |
Why?
| Metagenome | 1 | 2018 | 44 | 0.040 |
Why?
| Biodiversity | 1 | 2018 | 60 | 0.040 |
Why?
| Community-Based Participatory Research | 1 | 2020 | 209 | 0.040 |
Why?
| Bile Acids and Salts | 1 | 2018 | 76 | 0.040 |
Why?
| Depression | 1 | 2023 | 594 | 0.040 |
Why?
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2017 | 8 | 0.040 |
Why?
| Phylogeny | 1 | 2018 | 269 | 0.040 |
Why?
| RNA | 1 | 2018 | 202 | 0.040 |
Why?
| AMP-Activated Protein Kinases | 1 | 2017 | 29 | 0.040 |
Why?
| Mice, Knockout | 1 | 2020 | 926 | 0.040 |
Why?
| Myocardium | 1 | 2020 | 441 | 0.040 |
Why?
| Thinness | 1 | 2016 | 57 | 0.040 |
Why?
| Skull | 1 | 2016 | 79 | 0.040 |
Why?
| Thiazolidinediones | 1 | 2016 | 95 | 0.030 |
Why?
| Anisotropy | 1 | 2015 | 63 | 0.030 |
Why?
| Child Language | 1 | 2014 | 11 | 0.030 |
Why?
| Intelligence Tests | 1 | 2014 | 44 | 0.030 |
Why?
| Intelligence | 1 | 2014 | 63 | 0.030 |
Why?
| Proto-Oncogene Proteins c-fos | 1 | 2014 | 65 | 0.030 |
Why?
| Culture Media | 1 | 2014 | 100 | 0.030 |
Why?
| Microarray Analysis | 1 | 2014 | 84 | 0.030 |
Why?
| Glucose | 1 | 2016 | 366 | 0.030 |
Why?
| Proteins | 1 | 2017 | 376 | 0.030 |
Why?
| Cell Adhesion Molecules | 1 | 2014 | 87 | 0.030 |
Why?
| DNA Primers | 1 | 2014 | 225 | 0.030 |
Why?
| Human Umbilical Vein Endothelial Cells | 1 | 2014 | 95 | 0.030 |
Why?
| Diffusion Magnetic Resonance Imaging | 1 | 2014 | 126 | 0.030 |
Why?
| Activating Transcription Factor 3 | 1 | 2013 | 9 | 0.030 |
Why?
| Osteogenesis | 1 | 2016 | 377 | 0.030 |
Why?
| Trophoblasts | 1 | 2013 | 29 | 0.030 |
Why?
| Interleukin-8 | 1 | 2013 | 97 | 0.030 |
Why?
| Serum Response Factor | 1 | 2013 | 41 | 0.030 |
Why?
| Neuropsychological Tests | 1 | 2014 | 363 | 0.030 |
Why?
| Genotype | 1 | 2014 | 599 | 0.030 |
Why?
| MAP Kinase Signaling System | 1 | 2013 | 133 | 0.030 |
Why?
| Blotting, Western | 1 | 2014 | 683 | 0.030 |
Why?
| Cells, Cultured | 1 | 2016 | 1737 | 0.030 |
Why?
| Cell Proliferation | 1 | 2016 | 1096 | 0.030 |
Why?
| Interleukin-6 | 1 | 2013 | 315 | 0.030 |
Why?
| Milk Substitutes | 1 | 2010 | 6 | 0.020 |
Why?
| Speech Acoustics | 1 | 2010 | 21 | 0.020 |
Why?
| Diarrhea, Infantile | 1 | 2009 | 5 | 0.020 |
Why?
| Rotavirus Infections | 1 | 2009 | 7 | 0.020 |
Why?
| Rats | 1 | 2016 | 3415 | 0.020 |
Why?
| Single-Blind Method | 1 | 2009 | 120 | 0.020 |
Why?
| Testis | 1 | 2009 | 65 | 0.020 |
Why?
| Signal Transduction | 1 | 2016 | 1753 | 0.020 |
Why?
| Uterus | 1 | 2009 | 98 | 0.020 |
Why?
| Prostate | 1 | 2009 | 117 | 0.020 |
Why?
| Bone Development | 1 | 2009 | 69 | 0.020 |
Why?
| Animals, Newborn | 1 | 2009 | 396 | 0.020 |
Why?
|
|
Andres's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|